Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Eliot N. Mostow MD, MPH Associate Editor

See All Experts

featured

Published in Dermatology and

Journal Scan / Research · July 09, 2020

Multisystem Inflammatory Syndrome in US Children and Adolescents

The New England Journal of Medicine

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Additional Info

Multisystem Inflammatory Syndrome in Children in New York State

Disclosure statements are available on the authors' profiles:

Sarah Chamlin MD

The New England Journal of Medicine

Multisystem Inflammatory Syndrome in U.S. Children and Adolescents

N. Engl. J. Med 2020 Jun 29;[EPub Ahead of Print], LR Feldstein, EB Rose, SM Horwitz, JP Collins, MM Newhams, MBF Son, JW Newburger, LC Kleinman, SM Heidemann, AA Martin, AR Singh, S Li, KM Tarquinio, P Jaggi, ME Oster, SP Zackai, J Gillen, AJ Ratner, RF Walsh, JC Fitzgerald, MA Keenaghan, H Alharash, S Doymaz, KN Clouser, JS Giuliano Jr, A Gupta, RM Parker, AB Maddux, V Havalad, S Ramsingh, H Bukulmez, TT Bradford, LS Smith, MW Tenforde, CL Carroll, BJ Riggs, SJ Gertz, A Daube, A Lansell, A Coronado Munoz, CV Hobbs, KL Marohn, NB Halasa, MM Patel, AG Randolph

Multisystem Inflammatory Syndrome in US Children and Adolescents

Additional Info

Multisystem Inflammatory Syndrome in U.S. Children and Adolescents

Further Reading

Evaluation and Surgical Management of Pediatric Cutaneous Melanoma, Atypical Spitz Tumors, and Non-Spitz Melanocytic Tumors

Safety of Biologic Use During Pregnancy and Breastfeeding in Dermatology

Impact of Clinical Information on Melanocytic Skin Lesion Pathology Diagnosis

Local Recurrence, Metastasis, and Mortality Rates Among Patients With Thin and In Situ Melanomas

Suicidal and Self-Injurious Behaviors Among Patients With Psoriasis or Psoriatic Arthritis Treated With Biologics

Association Between Treatment With Biologics and Cardiovascular Comorbidities in Patients With Psoriasis

Efficacy and Safety of Upadacitinib vs Dupilumab in Adults and Adolescents With Moderate to Severe Atopic Dermatitis

Efficacy of Treatment With Upadacitinib in Adolescents With Moderate to Severe Atopic Dermatitis Through 76 Weeks

Non-SCORTEN Predictors of Mortality Among Patients With SJS/TEN

Risk Factors for Subclinical Spread in Patients With Melanoma In Situ and Invasive Melanoma

Outcomes of Dermoscopic vs Naked-Eye Evaluation of Surgical Margins in Patients With Nonmelanoma Skin Cancer Undergoing Mohs Micrographic Surgery

Recently Updated